Recording of M4K Pharma's Scientific Update Meeting - August 15th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]
Can an open drug discovery model find a solution for rare brain cancers in children? Dr. Aled Edwards OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers. Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival [...]
Recording of M4K Pharma's Scientific Update Meeting - July 18th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]
Recording of M4K Pharma's Scientific Update Meeting - June 6th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join the live meetings. To find out when our next meeting will be, follow [...]
Reaction Biology Joins the Fight Against DIPG with M4K Pharma [News Release] Malvern, PA- May 23, 2018. Reaction Biology Corporation (“RBC”), a leading contract research organization providing early stage drug discovery services, announced that it has partnered with M4K Pharma (“M4K”), an open science drug discovery and development company, in the fight against diffuse [...]
M4K Pharma Open Scientific Update Meeting May 2018- Recording Full recording from M4K Pharma's Scientific Update Meeting - May 9th, 2018. Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join [...]
M4K Pharma's Lemon Face Challenge for DIPG Watch the M4K team in Toronto complete the #LemonFaceChallenge to spread DIPG awareness, along with the Structural Genomics Consortium (SGC) and the Ontario Institute for Cancer Research (OICR). Charles River Laboratories met our challenge to them with their own lemon faces in this video here: https://twitter.com/hamblin_nicole/status/989234916872327170 [...]
Video recording of M4K’s April Scientific Update meeting Catch M4K Pharma’s virtual Scientific Update Meeting from April 6th, 2018 where our scientists and collaborators discussed the latest progress in our Medicines4Kids project for diffuse intrinsic pontine gliomas (DIPG).
[Podcast] Bio2040 interviews M4K Pharma's Owen Roberts In a podcast interview with Bio2040, CEO Owen Roberts discusses M4K Pharma's business model and why open science and sharing can be the path to finding medicines for rare diseases like DIPG.
Video recording of M4K's March Scientific Update meeting! Listen to M4K Pharma's virtual Scientific Update Meeting from March 7th, 2018 where our scientists and collaborators discussed the latest progress in M4K's Medicines4Kids project for diffuse intrinsic pontine gliomas (DIPG). Everyone is invited to see the chemistry first-hand! https://youtu.be/Ip-2QVhmhZc
